Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate Effects on Motivated Behavior in ADHD
NCT02630017Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Mar 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University of Arkansas. Started Mar 2016; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02630017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02630017.